Hyperion Catalysis International Inc - Cambridge, Massachusetts 02138

Hyperion Catalysis International Inc is categorized under Research and Development Laboratories in Cambridge, MA .

Business Name: Hyperion Catalysis International Inc
Address: 38 Smith Place, Cambridge, Massachusetts 02138
Phone Number: (617) 354-9678
Website Address: hyperioncatalysis.com
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 5417110
Share This Business:
Related Businesses: Soane Energy LLC - Cambridge, MA 02138
Cellendyne - Cambridge, MA 02138
Molecmo Nanobiotechnologies - Cambridge, MA 02138
Cromesett Energy Technologies LLC - Cambridge, MA 02138
Jounce Therapeutics Inc - Cambridge, MA 02138
Soane Labs LLC - Cambridge, MA 02138
Avogadro Inc - Cambridge, MA 02138
Bnw Technologies - Cambridge, MA 02138
Novobiotic Pharmaceuticals LLC - Cambridge, MA 02138
Cambridge Chemical Techs - Cambridge, MA 02138
Radcliff - Cambridge, MA 02138
Quintiles - Cambridge, MA 02138
Boston Micromachines Corp - Cambridge, MA 02138
Hstar Technologies Corp - Cambridge, MA 02138

The company Hyperion Catalysis International Inc provides B2B services in the form of Research and Development Laboratories from its single location in Massachusetts. 1 to 4 employees work for Hyperion Catalysis International Inc, and the business now earns Unknown per annum.

Hyperion Catalysis International Inc was launched in 0 and is classified under SIC code and category 8731 , and NAICS number and grouping 5417110 . To contact Hyperion Catalysis International Inc, please call with the phone number (617) 354-9678 or visit its single location at 38 Smith Place in Cambridge, Massachusetts 02138.

The location of the single location can also be found using the coordinates 42.39236,-71.1506. Read more details about this business on the webpage hyperioncatalysis.com or follow the company’s social media accounts, on Twitter and on Facebook.